tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Lexicon Pharmaceuticals Inc

LXRX
Add to Watchlist
2.310USD
-0.030-1.28%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.03BMarket Cap
LossP/E TTM

Lexicon Pharmaceuticals Inc

2.310
-0.030-1.28%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

LXRX Financials

See Lexicon Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Lexicon Pharmaceuticals Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.05
Revenue / Forecast
--/4.00M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
49.80M
60.24%
EPS(YoY)
-0.14
77.86%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
96.26%0.00
54.22%-0.04
80.40%-0.04
105.21%0.01
64.58%-0.07
54.01%-0.09
13.09%-0.18
21.61%-0.17
-16.73%-0.20
-25.76%-0.20
---0.21
---0.22
---0.17
---0.16
---0.45
----
----
----
----
----
Revenue
1572.11%21.10M
-79.31%5.49M
710.40%14.18M
1652.64%28.87M
11.68%1.26M
3682.62%26.55M
980.25%1.75M
419.56%1.65M
4608.33%1.13M
2407.14%702.00K
315.38%162.00K
805.71%317.00K
-35.14%24.00K
100.00%28.00K
69.57%39.00K
-85.04%35.00K
37.04%37.00K
-92.96%14.00K
-99.65%23.00K
-97.45%234.00K
Net Profit
95.88%-1.04M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.30M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.40M
-63.17%-49.76M
-116.04%-50.52M
-82.63%-44.90M
-36.03%-31.93M
-19.07%-30.49M
-1.15%-23.39M
-36.09%-24.59M
-12.01%-23.48M
-366.08%-25.61M
-127.99%-23.12M
73.84%-18.07M
Net Margin
99.75%-4.94%
-122.34%-282.72%
97.57%-90.04%
100.35%11.27%
53.20%-2004.36%
98.21%-127.16%
88.13%-3703.49%
77.10%-3244.02%
96.78%-4282.92%
93.49%-7087.75%
---31188.27%
---14165.30%
---133058.33%
---108907.14%
---64369.37%
----
----
----
----
----
Gross Margin
1.91%99.49%
-2.38%96.34%
4.16%99.93%
11.08%99.89%
0.38%97.62%
9.62%98.69%
0.28%95.94%
-7.75%89.92%
-2.74%97.26%
-9.97%90.03%
--95.68%
--97.48%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
-45.37%18.48%
-13.14%29.19%
-11.79%27.44%
-6.67%24.87%
41.32%33.83%
-22.51%33.61%
-13.36%31.11%
-14.54%26.65%
-20.26%23.94%
73.47%43.37%
--35.90%
--31.19%
--30.02%
--25.00%
--12.41%
----
----
----
----
----
Income Statement
Revenue
1572.11%21.10M
-79.31%5.49M
710.40%14.18M
1652.64%28.87M
11.68%1.26M
3682.62%26.55M
980.25%1.75M
419.56%1.65M
4608.33%1.13M
2407.14%702.00K
315.38%162.00K
805.71%317.00K
-35.14%24.00K
100.00%28.00K
69.57%39.00K
-85.04%35.00K
37.04%37.00K
-92.96%14.00K
-99.65%23.00K
-97.45%234.00K
Operating profit
96.12%-996.00K
54.85%-14.78M
80.87%-12.19M
106.75%3.74M
43.35%-25.68M
29.95%-32.74M
-28.33%-63.69M
-25.12%-55.35M
-45.57%-45.33M
-54.36%-46.74M
-114.90%-49.63M
-84.28%-44.24M
-33.20%-31.14M
-19.53%-30.28M
-0.58%-23.09M
-33.68%-24.01M
-12.19%-23.38M
-250.59%-25.33M
50.24%-22.96M
71.48%-17.96M
Net Profit
95.88%-1.04M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.30M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.40M
-63.17%-49.76M
-116.04%-50.52M
-82.63%-44.90M
-36.03%-31.93M
-19.07%-30.49M
-1.15%-23.39M
-36.09%-24.59M
-12.01%-23.48M
-366.08%-25.61M
-127.99%-23.12M
73.84%-18.07M
Balance Sheet
Current assets
-24.32%186.03M
-58.61%101.89M
-54.38%122.53M
-54.78%145.08M
-32.59%245.81M
39.45%246.19M
20.25%268.61M
21.66%320.84M
232.87%364.65M
25.33%176.55M
60.63%223.37M
306.36%263.72M
23.88%109.55M
58.42%140.87M
12.14%139.06M
-47.35%64.90M
-39.19%88.43M
-43.62%88.92M
1.70%124.00M
-49.93%123.26M
Total current liabilities
-91.06%9.90M
-53.88%20.87M
-39.74%21.72M
24.97%34.84M
373.07%110.69M
43.43%45.25M
11.73%36.05M
6.77%27.88M
14.86%23.40M
36.14%31.55M
74.90%32.26M
54.84%26.11M
7.75%20.37M
4.74%23.17M
-46.14%18.45M
-48.61%16.86M
-51.52%18.91M
-52.73%22.12M
-56.61%34.25M
-66.36%32.81M
Total assets
-9.69%268.82M
-38.01%184.99M
-35.87%205.93M
-39.58%225.58M
-28.65%297.67M
30.07%298.42M
16.15%321.12M
17.88%373.36M
156.41%417.22M
18.08%229.43M
44.24%276.48M
181.97%316.72M
19.49%162.72M
41.92%194.30M
11.23%191.69M
-34.57%112.33M
-29.54%136.18M
-32.82%136.91M
-3.69%172.33M
-46.77%171.67M
Total liabilities
-62.23%65.96M
-49.20%77.45M
-39.86%85.77M
-27.92%96.14M
36.06%174.64M
11.85%152.47M
4.12%142.61M
2.31%133.38M
71.89%128.35M
76.64%136.32M
187.35%136.97M
214.17%130.36M
71.73%74.67M
231.02%77.17M
33.42%47.67M
20.49%41.49M
6.80%43.48M
-50.83%23.31M
-60.86%35.73M
-89.67%34.44M
Total equity
64.88%202.86M
-26.32%107.54M
-32.69%120.16M
-46.06%129.44M
-57.41%123.03M
56.75%145.95M
27.96%178.51M
28.77%239.98M
228.09%288.87M
-20.50%93.11M
-3.13%139.51M
163.11%186.36M
-5.02%88.05M
3.11%117.12M
5.43%144.02M
-48.39%70.83M
-39.23%92.70M
-27.36%113.59M
55.87%136.60M
1384.11%137.23M
Cash Flow Statement
Net operating income
66.35%-14.73M
19.81%-17.23M
55.55%-23.83M
135.01%16.99M
20.59%-43.78M
57.48%-21.49M
-28.83%-53.62M
-27.34%-48.54M
-74.39%-55.13M
-134.35%-50.55M
-114.10%-41.62M
-56.08%-38.12M
-34.98%-31.61M
5.52%-21.57M
-13.35%-19.44M
-11.62%-24.42M
6.91%-23.42M
33.33%-22.83M
57.53%-17.15M
52.74%-21.88M
Net investment
-273.14%-70.26M
-91.01%4.83M
-2.51%52.13M
225.64%15.48M
136.82%40.58M
3.47%53.70M
235.96%53.47M
83.48%-12.32M
-1011.47%-110.22M
114.69%51.90M
49.06%-39.33M
-446.66%-74.61M
374.34%12.09M
296.56%24.17M
-19199.00%-77.20M
-196.53%-13.65M
75.13%-4.41M
-86.18%6.10M
-100.19%-400.00K
-81.89%14.14M
Net financing
15616.78%88.76M
-2714.42%-2.93M
100.00%0.00
-321328.57%-45.00M
-100.24%-572.00K
-10300.00%-104.00K
-336.19%-916.00K
-100.01%-14.00K
29151.33%239.38M
-100.00%-1.00K
-100.22%-210.00K
--189.00M
-103.54%-824.00K
320.00%24.91M
375.30%94.02M
100.00%0.00
63.14%23.28M
-117.65%-11.32M
109.41%19.78M
94.59%-23.00K

FAQs

What is the total revenue of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 49.80M, with a year-on-year change of 31.08M.

What are the current assets of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its current assets were 101.89M, with a year-on-year change of -58.61.

What are the total assets of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its total assets of Lexicon Pharmaceuticals Inc were 184.99M, with a year-on-year change of -38.01.

What are the total liabilities of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Lexicon Pharmaceuticals Inc were 77.45M, with a year-on-year change of -49.20.

What is the total equity of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its total equity of Lexicon Pharmaceuticals Inc was 107.54M, with a year-on-year change of -26.32.

What is the net operating income of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Lexicon Pharmaceuticals Inc was -48.91M, with a year-on-year change of 75.19.

What is the net investment of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its net investment of Lexicon Pharmaceuticals Inc was 113.02M, with a year-on-year change of 834.95.

What is the net financing of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its net financing of Lexicon Pharmaceuticals Inc was -48.50M, with a year-on-year change of -120.35.

What is the Earnings Per Share (EPS) of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.14, with a year-on-year change of 77.86.

What is the net income of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its net income was -50.34M, with a year-on-year change of 74.88.

What is the net margin of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -101.08, with a year-on-year change of 84.32.

What is the gross margin of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 99.45, with a year-on-year change of 1.46.

What is the debt-to-asset ratio of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 29.19, with a year-on-year change of -13.14.

What is the Return on Equity (ROE) of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -39.72, with a year-on-year change of 76.31.

What is the Return on Assets (ROA) of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -20.83, with a year-on-year change of 72.57.

What is the operating profit of Lexicon Pharmaceuticals Inc?

According to Lexicon Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -48.91M, with a year-on-year change of 75.19.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy